Profile
Greg Zarbis-Papastoitsis worked as the Head of Process Sciences & Manufacturing at Sesen Bio, Inc. from 2013 to 2016.
He received his undergraduate and doctorate degrees from the State University of New York at Binghamton.
Former positions of Greg Zarbis-Papastoitsis
| Companies | Position | End |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 2016-05-31 |
Training of Greg Zarbis-Papastoitsis
| State University of New York at Binghamton | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Greg Zarbis-Papastoitsis
